ONTOLOGY REPORT - ANNOTATIONS
| Term: | corticosterone |
|
| Accession: | CHEBI:16827
|
browse the term
|
| Definition: | Corticosterone is a 21-carbon steroid hormone of the corticosteroid type produced in the cortex of the adrenal glands. |
| Synonyms: | exact_synonym: | 11beta,21-dihydroxypregn-4-ene-3,20-dione |
| | related_synonym: | (11beta)-11,21-dihydroxypregn-4-ene-3,20-dione; 11beta,21-Dihydroxy-4-pregnene-3,20-dione; 11beta,21-dihydroxyprogesterone; 17-deoxycortisol; C21H30O4; InChI=1S/C21H30O4/c1-20-8-7-13(23)9-12(20)3-4-14-15-5-6-16(18(25)11-22)21(15,2)10-17(24)19(14)20/h9,14-17,19,22,24H,3-8,10-11H2,1-2H3/t14-,15-,16+,17-,19+,20-,21-/m0/s1; InChIKey=OMFXVFTZEKFJBZ-HJTSIMOOSA-N; Kendall's compound B; Reichstein's substance H; [H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(=O)CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C)C(=O)CO |
| | alt_id: | CHEBI:14022; CHEBI:19131; CHEBI:3891; CHEBI:41361; CHEBI:57911 |
| | xref_casrn: | 50-22-6 |
| | xref: | ChEMBL:282165 "ChEMBL COMPOUND"; ChemIDplus:2339601 "Beilstein Registry Number"; ChemIDplus:50-22-6 "CAS Registry Number"; CiteXplore:10438974 "PubMed citation"; KEGG COMPOUND:50-22-6 "CAS Registry Number"; KEGG COMPOUND:C02140 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D003345 |
| | xref: | NIST Chemistry WebBook:50-22-6 "CAS Registry Number"; PDBeChem:C0R "PDBeChem"; Wikipedia:Corticosterone "Wikipedia" |
|
|
corticosterone
|
| G |
A2M |
alpha-2-macroglobulin |
|
increases expression |
ISO |
12 |
9,220,304 |
9,268,558 |
RGD:6480464 |
CTD |
| G |
ABCG2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
decreases activity |
EXP |
4 |
89,011,416 |
89,152,474 |
RGD:6480464 |
CTD |
| G |
ACACA |
acetyl-CoA carboxylase alpha |
|
multiple interactions |
ISO |
17 |
35,441,927 |
35,766,902 |
RGD:6480464 |
CTD |
| G |
ACE |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
increases expression |
ISO |
17 |
61,554,422 |
61,575,741 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACLY |
ATP citrate lyase |
|
multiple interactions |
ISO |
17 |
40,023,179 |
40,075,272 |
RGD:6480464 |
CTD |
| G |
ACTA1 |
actin, alpha 1, skeletal muscle |
|
increases expression |
ISO |
1 |
229,566,992 |
229,569,843 |
RGD:6480464 |
CTD |
| G |
ACTG2 |
actin, gamma 2, smooth muscle, enteric |
|
increases expression |
ISO |
2 |
74,120,093 |
74,146,780 |
RGD:6480464 |
CTD |
| G |
ADAMTS1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
|
increases expression |
ISO |
21 |
28,208,606 |
28,217,728 |
RGD:6480464 |
CTD |
| G |
ADM |
adrenomedullin |
|
increases expression |
ISO |
11 |
10,326,642 |
10,328,923 |
RGD:6480464 |
CTD |
| G |
ADRB2 |
adrenoceptor beta 2, surface |
|
increases expression |
ISO |
5 |
148,206,156 |
148,208,197 |
RGD:6480464 |
CTD |
| G |
ALDH18A1 |
aldehyde dehydrogenase 18 family, member A1 |
|
decreases expression |
ISO |
10 |
97,365,686 |
97,416,567 |
RGD:6480464 |
CTD |
| G |
ANGPTL2 |
angiopoietin-like 2 |
|
decreases expression |
ISO |
9 |
129,849,628 |
129,885,044 |
RGD:6480464 |
CTD |
| G |
AQP1 |
aquaporin 1 (Colton blood group) |
|
increases expression |
ISO |
7 |
30,951,415 |
30,965,131 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
affects binding |
ISO |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
increases activity |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
ARRB1 |
arrestin, beta 1 |
|
decreases expression |
ISO |
11 |
74,971,166 |
75,062,875 |
RGD:6480464 |
CTD |
| G |
ARRB1 |
arrestin, beta 1 |
|
multiple interactions |
ISO |
11 |
74,971,166 |
75,062,875 |
RGD:6480464 |
CTD |
| G |
ARRB2 |
arrestin, beta 2 |
|
decreases expression |
ISO |
17 |
4,613,789 |
4,624,795 |
RGD:6480464 |
CTD |
| G |
ARRB2 |
arrestin, beta 2 |
|
multiple interactions |
ISO |
17 |
4,613,789 |
4,624,795 |
RGD:6480464 |
CTD |
| G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
ISO |
7 |
97,481,429 |
97,501,854 |
RGD:6480464 |
CTD |
| G |
ATP1A3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
ISO |
19 |
42,470,734 |
42,498,428 |
RGD:6480464 |
CTD |
| G |
ATP6V1G1 |
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 |
|
decreases expression |
ISO |
9 |
117,349,994 |
117,361,152 |
RGD:6480464 |
CTD |
| G |
AURKB |
aurora kinase B |
|
decreases expression |
ISO |
17 |
8,108,049 |
8,113,944 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
increases expression |
ISO |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BEX1 |
brain expressed, X-linked 1 |
|
decreases expression |
ISO |
X |
102,317,581 |
102,319,168 |
RGD:6480464 |
CTD |
| G |
BMP2 |
bone morphogenetic protein 2 |
|
increases expression |
ISO |
20 |
6,748,745 |
6,760,910 |
RGD:6480464 |
CTD |
| G |
BMP6 |
bone morphogenetic protein 6 |
|
increases expression |
ISO |
6 |
7,727,011 |
7,881,961 |
RGD:6480464 |
CTD |
| G |
BTG2 |
BTG family, member 2 |
|
increases expression |
ISO |
1 |
203,274,664 |
203,278,730 |
RGD:6480464 |
CTD |
| G |
C2orf40 |
chromosome 2 open reading frame 40 |
|
decreases expression |
ISO |
2 |
106,682,113 |
106,694,611 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
affects expression |
ISO |
19 |
6,677,846 |
6,720,662 |
RGD:6480464 |
CTD |
| G |
CALCA |
calcitonin-related polypeptide alpha |
|
increases abundance |
ISO |
11 |
14,988,215 |
14,993,832 |
RGD:6480464 |
CTD |
| G |
CAPN6 |
calpain 6 |
|
decreases expression |
ISO |
X |
110,488,327 |
110,513,774 |
RGD:6480464 |
CTD |
| G |
CARS |
cysteinyl-tRNA synthetase |
|
decreases expression |
ISO |
11 |
3,022,152 |
3,078,681 |
RGD:6480464 |
CTD |
| G |
CARTPT |
CART prepropeptide |
|
increases abundance |
ISO |
5 |
71,014,990 |
71,016,875 |
RGD:6480464 |
CTD |
| G |
CARTPT |
CART prepropeptide |
|
multiple interactions |
ISO |
5 |
71,014,990 |
71,016,875 |
RGD:6480464 |
CTD |
| G |
CASP12 |
caspase 12 (gene/pseudogene) |
|
decreases expression |
ISO |
11 |
104,756,445 |
104,769,397 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
increases activity |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
decreases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND2 |
cyclin D2 |
|
decreases expression |
ISO |
12 |
4,382,902 |
4,414,522 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
decreases expression |
ISO |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CD200 |
CD200 molecule |
|
decreases expression |
ISO |
3 |
112,051,916 |
112,081,659 |
RGD:6480464 |
CTD |
| G |
CD59 |
CD59 molecule, complement regulatory protein |
|
increases expression |
ISO |
11 |
33,724,556 |
33,758,025 |
RGD:6480464 |
CTD |
| G |
CDC20 |
cell division cycle 20 |
|
decreases expression |
ISO |
1 |
43,824,626 |
43,828,874 |
RGD:6480464 |
CTD |
| G |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
|
multiple interactions |
ISO |
18 |
25,530,930 |
25,757,445 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
multiple interactions |
ISO |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases expression |
ISO |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases activity |
ISO |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases activity |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases activity |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
affects expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
multiple interactions |
ISO |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
increases expression |
ISO |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
|
decreases expression |
ISO |
9 |
21,967,751 |
21,994,490 |
RGD:6480464 |
CTD |
| G |
CDO1 |
cysteine dioxygenase, type I |
|
increases expression |
ISO |
5 |
115,140,430 |
115,152,405 |
RGD:6480464 |
CTD |
| G |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
20 |
48,807,120 |
48,809,227 |
RGD:6480464 |
CTD |
| G |
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
8 |
48,649,476 |
48,650,726 |
RGD:6480464 |
CTD |
| G |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
9 |
91,926,113 |
91,931,618 |
RGD:6480464 |
CTD |
| G |
CNR1 |
cannabinoid receptor 1 (brain) |
|
increases abundance |
ISO |
6 |
88,849,583 |
88,875,767 |
RGD:6480464 |
CTD |
| G |
CP |
ceruloplasmin (ferroxidase) |
|
increases expression |
ISO |
3 |
148,880,197 |
148,939,832 |
RGD:6480464 |
CTD |
| G |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
|
increases expression |
ISO |
11 |
68,522,088 |
68,609,399 |
RGD:6480464 |
CTD |
| G |
CRH |
corticotropin releasing hormone |
|
multiple interactions |
ISO |
8 |
67,088,612 |
67,090,846 |
RGD:6480464 |
CTD |
| G |
CRH |
corticotropin releasing hormone |
|
increases abundance |
ISO |
8 |
67,088,612 |
67,090,846 |
RGD:6480464 |
CTD |
| G |
CRH |
corticotropin releasing hormone |
|
affects expression |
ISO |
8 |
67,088,612 |
67,090,846 |
RGD:6480464 |
CTD |
| G |
CRH |
corticotropin releasing hormone |
|
multiple interactions |
ISO |
8 |
67,088,612 |
67,090,846 |
RGD:6480464 |
CTD |
| G |
CRHR1 |
corticotropin releasing hormone receptor 1 |
|
decreases expression |
ISO |
17 |
43,697,710 |
43,913,194 |
RGD:6480464 |
CTD |
| G |
CRISPLD2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
increases expression |
ISO |
16 |
84,853,587 |
84,943,116 |
RGD:6480464 |
CTD |
| G |
CRISPLD2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
increases expression |
ISO |
16 |
84,853,587 |
84,943,116 |
RGD:6480464 |
CTD |
| G |
CSRP2 |
cysteine and glycine-rich protein 2 |
|
increases expression |
ISO |
12 |
77,252,496 |
77,272,799 |
RGD:6480464 |
CTD |
| G |
CSRP3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
increases expression |
ISO |
11 |
19,203,577 |
19,232,118 |
RGD:6480464 |
CTD |
| G |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
multiple interactions |
ISO |
5 |
138,089,107 |
138,270,723 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
multiple interactions |
ISO |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CTSS |
cathepsin S |
|
increases expression |
ISO |
1 |
150,702,672 |
150,738,433 |
RGD:6480464 |
CTD |
| G |
CYP11B1 |
cytochrome P450, family 11, subfamily B, polypeptide 1 |
|
increases chemical synthesis |
EXP |
8 |
143,953,773 |
143,961,236 |
RGD:6480464 |
CTD |
| G |
CYP11B2 |
cytochrome P450, family 11, subfamily B, polypeptide 2 |
|
affects metabolic processing |
EXP |
8 |
143,991,975 |
143,999,259 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
increases expression |
ISO |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases metabolic processing |
ISO |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases metabolic processing |
ISO |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A5 |
cytochrome P450, family 3, subfamily A, polypeptide 5 |
|
increases metabolic processing |
ISO |
7 |
99,245,813 |
99,277,621 |
RGD:6480464 |
CTD |
| G |
DBI |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
increases expression |
ISO |
2 |
120,124,504 |
120,130,122 |
RGD:6480464 |
CTD |
| G |
DCXR |
dicarbonyl/L-xylulose reductase |
|
increases expression |
ISO |
17 |
79,993,757 |
79,995,573 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
decreases expression |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDT |
D-dopachrome tautomerase |
|
increases expression |
ISO |
22 |
24,313,554 |
24,322,019 |
RGD:6480464 |
CTD |
| G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
multiple interactions |
ISO |
10 |
54,074,041 |
54,077,417 |
RGD:6480464 |
CTD |
| G |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
|
increases expression |
ISO |
10 |
54,074,041 |
54,077,417 |
RGD:6480464 |
CTD |
| G |
DPEP1 |
dipeptidase 1 (renal) |
|
increases expression |
ISO |
16 |
89,679,716 |
89,704,839 |
RGD:6480464 |
CTD |
| G |
DPT |
dermatopontin |
|
decreases expression |
ISO |
1 |
168,664,695 |
168,698,442 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
increases secretion |
ISO |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EDN2 |
endothelin 2 |
|
increases secretion |
ISO |
1 |
41,944,446 |
41,950,344 |
RGD:6480464 |
CTD |
| G |
EDN3 |
endothelin 3 |
|
increases secretion |
ISO |
20 |
57,875,499 |
57,901,047 |
RGD:6480464 |
CTD |
| G |
EEF2K |
eukaryotic elongation factor-2 kinase |
|
increases expression |
ISO |
16 |
22,217,592 |
22,300,066 |
RGD:6480464 |
CTD |
| G |
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
|
increases expression |
ISO |
2 |
56,093,097 |
56,151,298 |
RGD:6480464 |
CTD |
| G |
EGLN3 |
egl nine homolog 3 (C. elegans) |
|
increases expression |
ISO |
14 |
34,393,421 |
34,420,284 |
RGD:6480464 |
CTD |
| G |
EZH2 |
enhancer of zeste homolog 2 (Drosophila) |
|
decreases expression |
ISO |
7 |
148,504,464 |
148,581,441 |
RGD:6480464 |
CTD |
| G |
FABP3 |
fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) |
|
decreases expression |
ISO |
1 |
31,838,100 |
31,845,923 |
RGD:6480464 |
CTD |
| G |
FABP7 |
fatty acid binding protein 7, brain |
|
affects expression |
ISO |
6 |
123,100,646 |
123,105,219 |
RGD:6480464 |
CTD |
| G |
FASN |
fatty acid synthase |
|
multiple interactions |
ISO |
17 |
80,036,214 |
80,056,106 |
RGD:6480464 |
CTD |
| G |
FBLN2 |
fibulin 2 |
|
decreases expression |
ISO |
3 |
13,590,625 |
13,679,922 |
RGD:6480464 |
CTD |
| G |
FBN2 |
fibrillin 2 |
|
increases expression |
ISO |
5 |
127,593,601 |
127,873,735 |
RGD:6480464 |
CTD |
| G |
FBN2 |
fibrillin 2 |
|
increases expression |
ISO |
5 |
127,593,601 |
127,873,735 |
RGD:6480464 |
CTD |
| G |
FLT1 |
fms-related tyrosine kinase 1 |
|
increases expression |
ISO |
13 |
28,874,483 |
29,069,265 |
RGD:6480464 |
CTD |
| G |
FMO1 |
flavin containing monooxygenase 1 |
|
increases expression |
ISO |
1 |
171,217,663 |
171,255,113 |
RGD:6480464 |
CTD |
| G |
FOXS1 |
forkhead box S1 |
|
decreases expression |
ISO |
20 |
30,432,103 |
30,433,420 |
RGD:6480464 |
CTD |
| G |
FSHB |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
ISO |
11 |
30,252,563 |
30,256,824 |
RGD:6480464 |
CTD |
| G |
FSTL3 |
follistatin-like 3 (secreted glycoprotein) |
|
increases expression |
ISO |
19 |
676,389 |
683,392 |
RGD:6480464 |
CTD |
| G |
FXYD6 |
FXYD domain containing ion transport regulator 6 |
|
decreases expression |
ISO |
11 |
117,707,691 |
117,748,201 |
RGD:6480464 |
CTD |
| G |
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa) |
|
multiple interactions |
ISO |
2 |
171,673,200 |
171,717,661 |
RGD:6480464 |
CTD |
| G |
GAL |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
11 |
68,451,983 |
68,458,643 |
RGD:6480464 |
CTD |
| G |
GAS6 |
growth arrest-specific 6 |
|
increases expression |
ISO |
13 |
114,523,522 |
114,567,046 |
RGD:6480464 |
CTD |
| G |
GATM |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
decreases expression |
ISO |
15 |
45,653,322 |
45,670,980 |
RGD:6480464 |
CTD |
| G |
GCNT1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
increases expression |
ISO |
9 |
79,056,582 |
79,122,332 |
RGD:6480464 |
CTD |
| G |
GJA5 |
gap junction protein, alpha 5, 40kDa |
|
increases expression |
ISO |
1 |
147,228,332 |
147,245,484 |
RGD:6480464 |
CTD |
| G |
GLT8D1 |
glycosyltransferase 8 domain containing 1 |
|
decreases expression |
ISO |
3 |
52,728,504 |
52,740,048 |
RGD:6480464 |
CTD |
| G |
GLUL |
glutamate-ammonia ligase |
|
increases expression |
ISO |
1 |
182,350,839 |
182,361,341 |
RGD:6480464 |
CTD |
| G |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
decreases expression |
ISO |
3 |
50,273,647 |
50,296,786 |
RGD:6480464 |
CTD |
| G |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
multiple interactions |
ISO |
3 |
50,273,647 |
50,296,786 |
RGD:6480464 |
CTD |
| G |
GPX3 |
glutathione peroxidase 3 (plasma) |
|
increases expression |
ISO |
5 |
150,399,999 |
150,408,554 |
RGD:6480464 |
CTD |
| G |
GREM1 |
gremlin 1, DAN family BMP antagonist |
|
decreases expression |
ISO |
15 |
33,010,205 |
33,026,870 |
RGD:6480464 |
CTD |
| G |
GRK5 |
G protein-coupled receptor kinase 5 |
|
increases expression |
ISO |
10 |
120,967,197 |
121,215,131 |
RGD:6480464 |
CTD |
| G |
GSTA3 |
glutathione S-transferase alpha 3 |
|
increases expression |
ISO |
6 |
52,761,437 |
52,774,496 |
RGD:6480464 |
CTD |
| G |
GSTM2 |
glutathione S-transferase mu 2 (muscle) |
|
increases expression |
ISO |
1 |
110,210,644 |
110,226,619 |
RGD:6480464 |
CTD |
| G |
HMGB2 |
high mobility group box 2 |
|
decreases expression |
ISO |
4 |
174,252,527 |
174,255,595 |
RGD:6480464 |
CTD |
| G |
HMGCS2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
increases expression |
ISO |
1 |
120,290,619 |
120,311,555 |
RGD:6480464 |
CTD |
| G |
HMGN2 |
high mobility group nucleosomal binding domain 2 |
|
decreases expression |
ISO |
1 |
26,798,902 |
26,803,133 |
RGD:6480464 |
CTD |
| G |
HMGN2 |
high mobility group nucleosomal binding domain 2 |
|
decreases expression |
ISO |
1 |
26,798,902 |
26,803,133 |
RGD:6480464 |
CTD |
| G |
HS3ST1 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 1 |
|
increases expression |
ISO |
4 |
11,399,988 |
11,430,537 |
RGD:6480464 |
CTD |
| G |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
increases chemical synthesis |
ISO |
1 |
209,859,525 |
209,908,295 |
RGD:6480464 |
CTD |
| G |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
increases expression |
ISO |
1 |
209,859,525 |
209,908,295 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
multiple interactions |
ISO |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
affects metabolic processing |
ISO |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
increases metabolic processing |
ISO |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSPB1 |
heat shock 27kDa protein 1 |
|
increases expression |
ISO |
7 |
75,931,875 |
75,933,614 |
RGD:6480464 |
CTD |
| G |
HSPB6 |
heat shock protein, alpha-crystallin-related, B6 |
|
increases expression |
ISO |
19 |
36,245,467 |
36,247,930 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases secretion |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
ISO |
13 |
47,405,677 |
47,471,211 |
RGD:6480464 |
CTD |
| G |
IER3 |
immediate early response 3 |
|
decreases expression |
ISO |
6 |
30,710,976 |
30,712,327 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
decreases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
increases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1R |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
15 |
99,192,761 |
99,507,759 |
RGD:6480464 |
CTD |
| G |
IGFBP5 |
insulin-like growth factor binding protein 5 |
|
decreases expression |
ISO |
2 |
217,536,828 |
217,560,272 |
RGD:6480464 |
CTD |
| G |
IGFBP6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
12 |
53,491,436 |
53,496,128 |
RGD:6480464 |
CTD |
| G |
IL15 |
interleukin 15 |
|
increases expression |
ISO |
4 |
142,557,749 |
142,655,140 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
increases chemical synthesis |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1RL1 |
interleukin 1 receptor-like 1 |
|
decreases expression |
ISO |
2 |
102,927,962 |
102,968,497 |
RGD:6480464 |
CTD |
| G |
IRS3P |
insulin receptor substrate 3, pseudogene |
|
increases expression |
ISO |
7 |
100,162,878 |
100,167,751 |
RGD:6480464 |
CTD |
| G |
ITGA1 |
integrin, alpha 1 |
|
decreases expression |
ISO |
5 |
52,084,136 |
52,249,485 |
RGD:6480464 |
CTD |
| G |
ITGA8 |
integrin, alpha 8 |
|
increases expression |
ISO |
10 |
15,559,088 |
15,761,770 |
RGD:6480464 |
CTD |
| G |
ITGB1BP2 |
integrin beta 1 binding protein (melusin) 2 |
|
increases expression |
ISO |
X |
70,521,628 |
70,525,204 |
RGD:6480464 |
CTD |
| G |
JAK2 |
Janus kinase 2 |
|
multiple interactions |
ISO |
9 |
4,985,245 |
5,128,183 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
increases expression |
ISO |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNJ5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
ISO |
11 |
128,761,313 |
128,787,964 |
RGD:6480464 |
CTD |
| G |
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
multiple interactions |
ISO |
4 |
55,944,426 |
55,991,762 |
RGD:6480464 |
CTD |
| G |
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
decreases expression |
ISO |
4 |
55,944,426 |
55,991,762 |
RGD:6480464 |
CTD |
| G |
KIF15 |
kinesin family member 15 |
|
decreases expression |
ISO |
3 |
44,803,209 |
44,894,748 |
RGD:6480464 |
CTD |
| G |
KIFC1 |
kinesin family member C1 |
|
decreases expression |
ISO |
6 |
33,359,313 |
33,377,701 |
RGD:6480464 |
CTD |
| G |
KIFC1 |
kinesin family member C1 |
|
decreases expression |
ISO |
6 |
33,359,313 |
33,377,701 |
RGD:6480464 |
CTD |
| G |
KLF9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
9 |
72,999,513 |
73,029,573 |
RGD:6480464 |
CTD |
| G |
LEPRE1 |
leucine proline-enriched proteoglycan (leprecan) 1 |
|
decreases expression |
ISO |
1 |
43,212,006 |
43,232,755 |
RGD:6480464 |
CTD |
| G |
LMNB1 |
lamin B1 |
|
decreases expression |
ISO |
5 |
126,112,315 |
126,172,712 |
RGD:6480464 |
CTD |
| G |
LPAR1 |
lysophosphatidic acid receptor 1 |
|
increases expression |
ISO |
9 |
113,636,054 |
113,800,365 |
RGD:6480464 |
CTD |
| G |
MAGED2 |
melanoma antigen family D, 2 |
|
decreases expression |
ISO |
X |
54,834,171 |
54,842,445 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
decreases activity |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
decreases activity |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MB |
myoglobin |
|
decreases expression |
ISO |
22 |
36,002,811 |
36,019,401 |
RGD:6480464 |
CTD |
| G |
MCM3 |
minichromosome maintenance complex component 3 |
|
decreases expression |
ISO |
6 |
52,128,812 |
52,149,679 |
RGD:6480464 |
CTD |
| G |
MCM4 |
minichromosome maintenance complex component 4 |
|
decreases expression |
ISO |
8 |
48,872,763 |
48,890,720 |
RGD:6480464 |
CTD |
| G |
MCM6 |
minichromosome maintenance complex component 6 |
|
decreases expression |
ISO |
2 |
136,597,196 |
136,634,047 |
RGD:6480464 |
CTD |
| G |
MCM7 |
minichromosome maintenance complex component 7 |
|
decreases expression |
ISO |
7 |
99,690,404 |
99,699,427 |
RGD:6480464 |
CTD |
| G |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
decreases expression |
ISO |
6 |
83,920,108 |
84,140,938 |
RGD:6480464 |
CTD |
| G |
MELK |
maternal embryonic leucine zipper kinase |
|
decreases expression |
ISO |
9 |
36,572,859 |
36,677,680 |
RGD:6480464 |
CTD |
| G |
MGST2 |
microsomal glutathione S-transferase 2 |
|
increases expression |
ISO |
4 |
140,586,922 |
140,661,899 |
RGD:6480464 |
CTD |
| G |
MMP12 |
matrix metallopeptidase 12 (macrophage elastase) |
|
decreases expression |
ISO |
11 |
102,733,464 |
102,745,764 |
RGD:6480464 |
CTD |
| G |
MT1A |
metallothionein 1A |
|
increases expression |
ISO |
16 |
56,672,578 |
56,673,999 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
ISO |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MUSTN1 |
musculoskeletal, embryonic nuclear protein 1 |
|
increases expression |
ISO |
3 |
52,867,131 |
52,869,235 |
RGD:6480464 |
CTD |
| G |
MYH11 |
myosin, heavy chain 11, smooth muscle |
|
increases expression |
ISO |
16 |
15,796,992 |
15,950,887 |
RGD:6480464 |
CTD |
| G |
NCAPD2 |
non-SMC condensin I complex, subunit D2 |
|
decreases expression |
ISO |
12 |
6,603,298 |
6,641,132 |
RGD:6480464 |
CTD |
| G |
NCAPH2 |
non-SMC condensin II complex, subunit H2 |
|
decreases expression |
ISO |
22 |
50,946,645 |
50,963,209 |
RGD:6480464 |
CTD |
| G |
NCOA1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
EXP |
2 |
24,807,346 |
24,993,571 |
RGD:6480464 |
CTD |
| G |
NCS1 |
neuronal calcium sensor 1 |
|
increases expression |
ISO |
9 |
132,934,857 |
132,999,583 |
RGD:6480464 |
CTD |
| G |
NDRG1 |
N-myc downstream regulated 1 |
|
multiple interactions |
ISO |
8 |
134,249,414 |
134,309,547 |
RGD:6480464 |
CTD |
| G |
NDRG1 |
N-myc downstream regulated 1 |
|
increases phosphorylation |
ISO |
8 |
134,249,414 |
134,309,547 |
RGD:6480464 |
CTD |
| G |
NDRG2 |
NDRG family member 2 |
|
increases expression |
ISO |
14 |
21,484,922 |
21,493,935 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NOV |
nephroblastoma overexpressed |
|
increases expression |
ISO |
8 |
120,428,552 |
120,436,678 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
increases expression |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
multiple interactions |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPY |
neuropeptide Y |
|
decreases expression |
ISO |
7 |
24,323,807 |
24,331,484 |
RGD:6480464 |
CTD |
| G |
NR1I2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
EXP |
3 |
119,499,331 |
119,537,332 |
RGD:6480464 |
CTD |
| G |
NR1I2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
EXP |
3 |
119,499,331 |
119,537,332 |
RGD:6480464 |
CTD |
| G |
NR1I3 |
nuclear receptor subfamily 1, group I, member 3 |
|
multiple interactions |
ISO |
1 |
161,199,456 |
161,208,000 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
EXP |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
affects binding |
EXP |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases activity |
EXP |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases activity |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
affects abundance |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases activity |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
multiple interactions |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
|
affects binding |
EXP |
4 |
148,999,915 |
149,363,672 |
RGD:6480464 |
CTD |
| G |
NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
increases expression |
ISO |
15 |
88,419,988 |
88,799,962 |
RGD:6480464 |
CTD |
| G |
OMD |
osteomodulin |
|
increases expression |
ISO |
9 |
95,176,527 |
95,186,836 |
RGD:6480464 |
CTD |
| G |
OPLAH |
5-oxoprolinase (ATP-hydrolysing) |
|
increases expression |
ISO |
8 |
145,106,167 |
145,115,584 |
RGD:6480464 |
CTD |
| G |
ORM1 |
orosomucoid 1 |
|
increases expression |
ISO |
9 |
117,085,303 |
117,088,759 |
RGD:6480464 |
CTD |
| G |
PCK2 |
phosphoenolpyruvate carboxykinase 2 (mitochondrial) |
|
decreases expression |
ISO |
14 |
24,563,483 |
24,573,339 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PDK1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
multiple interactions |
ISO |
2 |
173,420,779 |
173,463,862 |
RGD:6480464 |
CTD |
| G |
PDLIM5 |
PDZ and LIM domain 5 |
|
increases expression |
ISO |
4 |
95,373,008 |
95,589,378 |
RGD:6480464 |
CTD |
| G |
PDLIM7 |
PDZ and LIM domain 7 (enigma) |
|
increases expression |
ISO |
5 |
176,910,395 |
176,924,602 |
RGD:6480464 |
CTD |
| G |
PDYN |
prodynorphin |
|
multiple interactions |
ISO |
20 |
1,959,402 |
1,974,931 |
RGD:6480464 |
CTD |
| G |
PDYN |
prodynorphin |
|
multiple interactions |
ISO |
20 |
1,959,402 |
1,974,931 |
RGD:6480464 |
CTD |
| G |
PENK |
proenkephalin |
|
multiple interactions |
ISO |
8 |
57,353,513 |
57,359,282 |
RGD:6480464 |
CTD |
| G |
PFKL |
phosphofructokinase, liver |
|
increases expression |
ISO |
21 |
45,719,925 |
45,747,261 |
RGD:6480464 |
CTD |
| G |
PFN2 |
profilin 2 |
|
decreases expression |
ISO |
3 |
149,682,691 |
149,688,741 |
RGD:6480464 |
CTD |
| G |
PIM3 |
pim-3 oncogene |
|
increases expression |
ISO |
22 |
50,354,143 |
50,357,720 |
RGD:6480464 |
CTD |
| G |
PLA1A |
phospholipase A1 member A |
|
increases expression |
ISO |
3 |
119,316,695 |
119,348,658 |
RGD:6480464 |
CTD |
| G |
PLK1 |
polo-like kinase 1 |
|
decreases expression |
ISO |
16 |
23,690,201 |
23,701,688 |
RGD:6480464 |
CTD |
| G |
PLK2 |
polo-like kinase 2 |
|
decreases expression |
ISO |
5 |
57,749,809 |
57,755,966 |
RGD:6480464 |
CTD |
| G |
PLK4 |
polo-like kinase 4 |
|
decreases expression |
ISO |
4 |
128,802,016 |
128,820,379 |
RGD:6480464 |
CTD |
| G |
PODXL |
podocalyxin-like |
|
increases expression |
ISO |
7 |
131,185,021 |
131,241,376 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
decreases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
decreases abundance |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
decreases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
multiple interactions |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases abundance |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases abundance |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
PPP1R1B |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
multiple interactions |
ISO |
17 |
37,783,177 |
37,792,878 |
RGD:6480464 |
CTD |
| G |
PPP2R2B |
protein phosphatase 2, regulatory subunit B, beta |
|
decreases expression |
ISO |
5 |
145,969,067 |
146,461,033 |
RGD:6480464 |
CTD |
| G |
PRIM1 |
primase, DNA, polypeptide 1 (49kDa) |
|
decreases expression |
ISO |
12 |
57,125,364 |
57,146,146 |
RGD:6480464 |
CTD |
| G |
PRKCA |
protein kinase C, alpha |
|
multiple interactions |
ISO |
17 |
64,298,926 |
64,806,862 |
RGD:6480464 |
CTD |
| G |
PTEN |
phosphatase and tensin homolog |
|
increases phosphorylation |
ISO |
10 |
89,623,195 |
89,728,532 |
RGD:6480464 |
CTD |
| G |
PTGDS |
prostaglandin D2 synthase 21kDa (brain) |
|
increases expression |
ISO |
9 |
139,871,956 |
139,876,194 |
RGD:6480464 |
CTD |
| G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
9 |
125,132,809 |
125,157,982 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTH |
parathyroid hormone |
|
multiple interactions |
ISO |
11 |
13,513,601 |
13,517,567 |
RGD:6480464 |
CTD |
| G |
PTPN3 |
protein tyrosine phosphatase, non-receptor type 3 |
|
decreases expression |
ISO |
9 |
112,137,974 |
112,260,593 |
RGD:6480464 |
CTD |
| G |
PTPN3 |
protein tyrosine phosphatase, non-receptor type 3 |
|
decreases expression |
ISO |
9 |
112,137,974 |
112,260,593 |
RGD:6480464 |
CTD |
| G |
PTTG1 |
pituitary tumor-transforming 1 |
|
decreases expression |
ISO |
5 |
159,848,865 |
159,855,746 |
RGD:6480464 |
CTD |
| G |
QSOX1 |
quiescin Q6 sulfhydryl oxidase 1 |
|
increases expression |
ISO |
1 |
180,123,968 |
180,167,169 |
RGD:6480464 |
CTD |
| G |
RAPGEF4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
|
increases expression |
ISO |
2 |
173,600,525 |
173,917,621 |
RGD:6480464 |
CTD |
| G |
RBP1 |
retinol binding protein 1, cellular |
|
decreases expression |
ISO |
3 |
139,236,276 |
139,258,671 |
RGD:6480464 |
CTD |
| G |
REG3A |
regenerating islet-derived 3 alpha |
|
decreases expression |
ISO |
2 |
79,384,132 |
79,386,880 |
RGD:6480464 |
CTD |
| G |
RETN |
resistin |
|
increases expression |
ISO |
19 |
7,733,972 |
7,735,340 |
RGD:6480464 |
CTD |
| G |
RFC3 |
replication factor C (activator 1) 3, 38kDa |
|
decreases expression |
ISO |
13 |
34,392,206 |
34,540,695 |
RGD:6480464 |
CTD |
| G |
RFC4 |
replication factor C (activator 1) 4, 37kDa |
|
decreases expression |
ISO |
3 |
186,507,681 |
186,524,484 |
RGD:6480464 |
CTD |
| G |
RGCC |
regulator of cell cycle |
|
increases expression |
ISO |
13 |
42,031,542 |
42,045,013 |
RGD:6480464 |
CTD |
| G |
RHOJ |
ras homolog family member J |
|
increases expression |
ISO |
14 |
63,671,102 |
63,760,230 |
RGD:6480464 |
CTD |
| G |
RPA2 |
replication protein A2, 32kDa |
|
decreases expression |
ISO |
1 |
28,218,049 |
28,241,236 |
RGD:6480464 |
CTD |
| G |
RRM1 |
ribonucleotide reductase M1 |
|
decreases expression |
ISO |
11 |
4,115,924 |
4,160,106 |
RGD:6480464 |
CTD |
| G |
SDC1 |
syndecan 1 |
|
decreases expression |
ISO |
2 |
20,400,558 |
20,425,194 |
RGD:6480464 |
CTD |
| G |
SDC2 |
syndecan 2 |
|
decreases expression |
ISO |
8 |
97,505,882 |
97,624,037 |
RGD:6480464 |
CTD |
| G |
SDC4 |
syndecan 4 |
|
increases expression |
ISO |
20 |
43,953,928 |
43,977,064 |
RGD:6480464 |
CTD |
| G |
SEPP1 |
selenoprotein P, plasma, 1 |
|
increases expression |
ISO |
5 |
42,799,982 |
42,812,024 |
RGD:6480464 |
CTD |
| G |
SERPINA3 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
|
increases expression |
ISO |
14 |
95,078,714 |
95,090,390 |
RGD:6480464 |
CTD |
| G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
6 |
134,490,384 |
134,639,196 |
RGD:6480464 |
CTD |
| G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
6 |
134,490,384 |
134,639,196 |
RGD:6480464 |
CTD |
| G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
6 |
134,490,384 |
134,639,196 |
RGD:6480464 |
CTD |
| G |
SGK1 |
serum/glucocorticoid regulated kinase 1 |
|
increases phosphorylation |
ISO |
6 |
134,490,384 |
134,639,196 |
RGD:6480464 |
CTD |
| G |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
11 |
35,272,752 |
35,441,610 |
RGD:6480464 |
CTD |
| G |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
EXP |
11 |
35,272,752 |
35,441,610 |
RGD:6480464 |
CTD |
| G |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
increases expression |
ISO |
11 |
35,272,752 |
35,441,610 |
RGD:6480464 |
CTD |
| G |
SLC22A11 |
solute carrier family 22 (organic anion/urate transporter), member 11 |
|
multiple interactions |
EXP |
11 |
64,323,098 |
64,338,999 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
decreases activity |
ISO |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
decreases activity |
EXP |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
ISO |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC22A3 |
solute carrier family 22 (extraneuronal monoamine transporter), member 3 |
|
multiple interactions |
EXP |
6 |
160,769,405 |
160,873,611 |
RGD:6480464 |
CTD |
| G |
SLC2A1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
increases expression |
ISO |
1 |
43,391,046 |
43,424,847 |
RGD:6480464 |
CTD |
| G |
SLC2A4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
17 |
7,185,054 |
7,191,367 |
RGD:6480464 |
CTD |
| G |
SMARCD2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2 |
|
increases expression |
ISO |
17 |
61,909,441 |
61,920,351 |
RGD:6480464 |
CTD |
| G |
SORBS2 |
sorbin and SH3 domain containing 2 |
|
increases expression |
ISO |
4 |
186,506,598 |
186,877,870 |
RGD:6480464 |
CTD |
| G |
SOX4 |
SRY (sex determining region Y)-box 4 |
|
decreases expression |
ISO |
6 |
21,593,972 |
21,598,850 |
RGD:6480464 |
CTD |
| G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
17 |
17,714,663 |
17,740,325 |
RGD:6480464 |
CTD |
| G |
STMN1 |
stathmin 1 |
|
decreases expression |
ISO |
1 |
26,210,677 |
26,233,368 |
RGD:6480464 |
CTD |
| G |
SULT1A1 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
|
increases expression |
ISO |
16 |
28,616,908 |
28,634,907 |
RGD:6480464 |
CTD |
| G |
TAT |
tyrosine aminotransferase |
|
multiple interactions |
ISO |
16 |
71,600,754 |
71,610,998 |
RGD:6480464 |
CTD |
| G |
TCF21 |
transcription factor 21 |
|
increases expression |
ISO |
6 |
134,210,259 |
134,216,675 |
RGD:6480464 |
CTD |
| G |
TCP1 |
t-complex 1 |
|
decreases expression |
ISO |
6 |
160,199,530 |
160,210,735 |
RGD:6480464 |
CTD |
| G |
TDO2 |
tryptophan 2,3-dioxygenase |
|
increases activity |
ISO |
4 |
156,824,845 |
156,841,558 |
RGD:6480464 |
CTD |
| G |
TF |
transferrin |
|
increases expression |
ISO |
3 |
133,464,977 |
133,497,850 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGM2 |
transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) |
|
increases expression |
ISO |
20 |
36,756,863 |
36,793,700 |
RGD:6480464 |
CTD |
| G |
TINAGL1 |
tubulointerstitial nephritis antigen-like 1 |
|
increases expression |
ISO |
1 |
32,042,086 |
32,053,287 |
RGD:6480464 |
CTD |
| G |
TK1 |
thymidine kinase 1, soluble |
|
decreases expression |
ISO |
17 |
76,170,160 |
76,183,285 |
RGD:6480464 |
CTD |
| G |
TNC |
tenascin C |
|
decreases expression |
ISO |
9 |
117,781,854 |
117,880,536 |
RGD:6480464 |
CTD |
| G |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression |
ISO |
8 |
119,935,796 |
119,964,383 |
RGD:6480464 |
CTD |
| G |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions |
ISO |
8 |
119,935,796 |
119,964,383 |
RGD:6480464 |
CTD |
| G |
TNFSF11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
ISO |
13 |
43,136,872 |
43,182,149 |
RGD:6480464 |
CTD |
| G |
TNFSF11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
ISO |
13 |
43,136,872 |
43,182,149 |
RGD:6480464 |
CTD |
| G |
TOP2A |
topoisomerase (DNA) II alpha 170kDa |
|
decreases expression |
ISO |
17 |
38,544,773 |
38,574,202 |
RGD:6480464 |
CTD |
| G |
TPBG |
trophoblast glycoprotein |
|
decreases expression |
ISO |
6 |
83,072,923 |
83,077,134 |
RGD:6480464 |
CTD |
| G |
TPD52L1 |
tumor protein D52-like 1 |
|
increases expression |
ISO |
6 |
125,474,879 |
125,584,644 |
RGD:6480464 |
CTD |
| G |
TRHR |
thyrotropin-releasing hormone receptor |
|
increases expression |
ISO |
8 |
110,099,653 |
110,131,813 |
RGD:6480464 |
CTD |
| G |
TRIM54 |
tripartite motif containing 54 |
|
increases expression |
ISO |
2 |
27,505,297 |
27,530,307 |
RGD:6480464 |
CTD |
| G |
TSPO |
translocator protein (18kDa) |
|
increases expression |
ISO |
22 |
43,547,520 |
43,559,248 |
RGD:6480464 |
CTD |
| G |
TUBB |
tubulin, beta class I |
|
decreases expression |
ISO |
6 |
30,688,157 |
30,693,199 |
RGD:6480464 |
CTD |
| G |
UBE2C |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
ISO |
20 |
44,441,255 |
44,445,596 |
RGD:6480464 |
CTD |
| G |
VCAN |
versican |
|
decreases expression |
ISO |
5 |
82,767,493 |
82,878,122 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
affects expression |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases expression |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
WARS |
tryptophanyl-tRNA synthetase |
|
decreases expression |
ISO |
14 |
100,800,125 |
100,842,680 |
RGD:6480464 |
CTD |
| G |
XPO1 |
exportin 1 (CRM1 homolog, yeast) |
|
decreases expression |
ISO |
2 |
61,705,069 |
61,765,418 |
RGD:6480464 |
CTD |
| G |
ZFP36 |
ZFP36 ring finger protein |
|
increases expression |
ISO |
19 |
39,897,487 |
39,900,052 |
RGD:6480464 |
CTD |
Term paths to the root
|